[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
3PrimeAnalytica posts on X about $ntla, $beam, stocks, $crsp the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.
Social category influence finance cryptocurrencies stocks currencies
Social topic influence $ntla #15, $beam #49, stocks, $crsp #13, $2bn, $edit, losses, $arkq, $arkw, $arkf
Top assets mentioned Intellia Therapeutics, Inc (NTLA) BEAM (BEAM) CRISPR Therapeutics AG (CRSP) AstraZeneca PLC (AZN)
Top posts by engagements in the last XX hours
"Recent study highlighted Generative AI able to design synthetic proteins superior to natural ones for genome editing. Training a protein language model on over 13000 PiggyBac-like enzyme sequences enabling the AI to create variants that insert DNA into human cells with greater efficiency and precision. Expands the Piggybac toolkit and also a useful approach for creating new gene-editing tools that enable accurate and effective genome alterations with broad apps across biotech and Tx"
X Link @3primeAnalytica 2025-10-05T13:47Z 1273 followers, XXX engagements
"Overnight looking good so far ππΌonly bought a tiny bit of $BEAM last Friday though"
X Link @3primeAnalytica 2025-10-13T00:30Z 1273 followers, 1719 engagements
"@GeneInvesting agree though trailing stop losses can be quite useful once you hit your PT and theres reason to believe theres some potential for further upside (esp. if adjusted to the stocks historical volatility)some times a good way to balance greed/fear in those cases"
X Link @3primeAnalytica 2025-10-13T00:06Z 1271 followers, XXX engagements
"after all these years π₯Ά still being up on $NTLA $BEAM $CRSP after broad market jitters/liquidations I'm reading about this a.m. hits different"
X Link @3primeAnalytica 2025-10-11T16:10Z 1273 followers, 1246 engagements
"Ladies & gents the Jim Cramer of Biotech strikes again π€‘"
X Link @3primeAnalytica 2025-10-10T17:49Z 1272 followers, 1609 engagements
"@VEGA_n1 patience deal was only announced last Friday and hasn't closed.Beam has X business days to file 8-K form too"
X Link @3primeAnalytica 2025-10-13T16:25Z 1271 followers, XX engagements
"π¨ANOTHER CRISPR 𧬠deal landed today - hot on the heels of the AZ deal with Algen.now Chiesi is betting up to $2bn on Arbor Biotechnologies' CRISPR tech to tackle rare disease PH1 with a one-time liver gene edit. CRISPR tech is on π₯π₯"
X Link @3primeAnalytica 2025-10-06T20:03Z 1271 followers, 1356 engagements
"@_OliverVenture π₯π₯now superimpose $ARKQ $ARKW $ARKF π"
X Link @3primeAnalytica 2025-10-13T00:21Z 1273 followers, XXX engagements
"π¨ CRISPR News π§¬: AstraZeneca $AZN seals a $555m deal with Algen Biotechnologies for exclusive rights to AI-powered CRISPR therapies targeting immune disorders and cancer - underscoring the tech's accelerating potential to transform DD & spark investor interest. CRISPR's future keeps shining π"
X Link @3primeAnalytica 2025-10-06T15:44Z 1271 followers, 3511 engagements
"Here's your Morning CRISPR Brief ββ Recap: gene editing stocks dipped 3-9% on Oct. 10th amid broader market weakness but fundamentals remain intact $CRSP -XXXX% $SANA -XXXX% $NTLA -XXXX% $BEAM -XXXX% $EDIT -XXXX% $PRME -XXXX% $CRBU -9.45%. Big Pharmas interest in CRISPR is heating up again π₯ as evidenced by several partnerships and deals just last week. The unveiling of a next-gen platform like SyNTase and good poc data reflects steady momentum in the gene editing sector. Some highlights from last week: 1) Non-dilutive win for @BeamTx: $BMY acquired Orbital Therapeutics BEAM's RNA"
X Link @3primeAnalytica 2025-10-13T13:17Z 1273 followers, 2893 engagements
"$NTLA binge continues into this week another $2M yesterday"
X Link @3primeAnalytica 2025-09-30T12:18Z 1271 followers, 3645 engagements
"$NTLA back $2bn mc"
X Link @3primeAnalytica 2025-10-01T14:16Z 1271 followers, 1405 engagements
"$NTLA and $EDIT will participate at Wainwright's Genetic Medicines Virtual Conference - fireside chat. October 14th. There's actually a webcast link for $NTLA this time. $EDIT also presenting EDIT-401 Oral Presentation At The European Society Of Gene And Cell Therapy (ESGCT) next week - Thursday 9th Oct"
X Link @3primeAnalytica 2025-10-06T20:29Z 1271 followers, XXX engagements
"Many wonderful patient stories are accumulating and surely more to come: β
Baby Tomas at UKs GOSH XX months old with OTC deficiency received gene editing last summer and is now off steroids special diets and meds. β
Alyssa also at UKs GOSH with incurable T-cell leukemia received the worlds first base-edited CAR-T cells in May 2022; now cancer-free and back home"
X Link @3primeAnalytica 2025-10-12T21:55Z 1271 followers, XXX engagements